SYRE Stock Analysis: Buy, Sell, or Hold?
SYRE - Spyre Therapeutics, Inc. Common Stock
$31.98
-1.60 (-4.76%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When SYRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SYRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SYRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SYRE is currently trading at $31.98, which is considered fair relative to its 30-day fair value range of $31.13 to $33.56.
Technical Outlook: Technically, SYRE is in a strong uptrend. The price is currently testing key support at $31.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $56.43 (+68.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SYRE is in a strong uptrend. The price is currently testing key support at $31.52. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $56.43 (+68.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$31.13 -
$33.56
Company Quality Score
58/100
(HOLD)
Options IV Signal
4th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 4th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 68.0% below Wall St target ($56.43)
Fair Price Analysis
30-Day Fair Range
$31.13 -
$33.56
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$3.37
(10.5%)
Support & Resistance Levels
Support Level
$31.52
Resistance Level
$35.07
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-11.99
Wall Street Target
$56.43
(+68.0%)
Earnings Growth (YoY)
-99.7%
Last updated: January 31, 2026 1:20 PM ET
Data refreshes hourly during market hours. Next update: 2:20 PM
Data refreshes hourly during market hours. Next update: 2:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott L Burrows
SELL
18428 shares
2025-09-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced SYRE Option Strategies
Professional options setups generated by AI based on today's SYRE price and gamma walls.
